ResMed (RMD) PT Lowered to $220 at Mizuho
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $191.89 -0.53%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 22 | New: 24
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 22 | New: 24
Join SI Premium – FREE
Mizuho analyst Anthony Petrone lowered the price target on ResMed (NYSE: RMD) to $220.00 (from $235.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Cantor Fitzgerald Downgrades DOMO (DOMO) to Neutral
- Crown Castle (CCI) PT Lowered to $96 at Bernstein SocGen Group
- Alphabet (GOOGL) PT Lowered to $350 at DA Davidson as Capex Set to Increase
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
